Investing Profile

R. Jacob Vogelstein

InvestorVCFounder

Co-Founder and Managing Partner at Catalio Capital Management

cataliocapital.com/team/r-jac...Bethesda

Your Intro Paths to R. Jacob Vogelstein

Signal uses Gmail to reveal intro paths. Email content is never read.

Networks R. Jacob is a member of

Brown University Network

216 CONNECTIONS

The Johns Hopkins University Network

35 CONNECTIONS

Aura Entertainment, Shooting Gallery, Morgan Creek Productions, Other Network

32 CONNECTIONS

Aura Entertainment, Shooting Gallery, Morgan Creek Productions, Other Network

32 CONNECTIONS

The Johns Hopkins University School of Medicine Network

19 CONNECTIONS

Find R. Jacob Vogelstein on

Current Investing Position

Catalio Capital Management Managing Partner

Investment Range

$100K - $5.0M

Sweet Spot

$1.5M

Investments On Record

R. Jacob Vogelstein is on these Sector & Stage Rankings

AI (Series B)BioTech (Series B)Medical Devices (Series B)Medical Devices (Series A)BioTech (Series A)AI (Series A)Washington, D.C.Drug Delivery (Series A)Diagnostics (Series B)Diagnostics (Series A)Drug Delivery (Series B)

R. Jacob Vogelstein's Investments On Record (9)

Company	StageDateRound Size	Total Raised
Flourish	Series AJun 2026$500M	$500M
Co-investors: David Frankel (Founder Collective), Jeff Bezos
Iambic	Series UnknownNov 2025$130M Series BOct 2023$100M Series AJul 2021$53M	$330M
Co-investors: Bill Coughran (Sequoia Capital), Wesley Yiu (Alumni Ventures ), Brian Keil (Chestnut Street Ventures), Kurt von Emster (Abingworth), Naren Gupta (Nexus Venture Partners), Jishnu Bhattacharjee (Nexus Venture Partners), Ayman AlAbdallah
Syndeio Biosciences	Series UnknownMay 2025$90M	$90M
Clasp Therapeutics	Series AMar 2024$150M	$150M
Co-investors: George C. Petrocheilos (Catalio Capital Management), Andrea van Elsas (Third Rock Ventures), Jack Nielsen (Vivo Capital)
NextPoint Therapeutics	Series BFeb 2024$43M	$120M
Co-investors: Paulina Hill (Polaris Partners), Detlev Biniszkiewicz (MPM BioImpact)
Haystack Oncology	Series ANov 2022$56M	$56M
Co-investors: George C. Petrocheilos (Catalio Capital Management)
Pheast Therapeutics	Series AApr 2022$76M	$76M
Co-investors: Steven Gillis (ARCH Venture Partners), George C. Petrocheilos (Catalio Capital Management)
Bayesian Health	Series UnknownJul 2021$15M	$15M
Co-investors: Vineeta Agarwala (Andreessen Horowitz), Julie Yoo (Andreessen Horowitz), Vijay Pande (Andreessen Horowitz)

R. Jacob Vogelstein's Experience

Program Manager, Applied Neuroscience Johns Hopkins Applied Physics LaboratoryPresent

Program Manager, Applied Neuroscience The Johns Hopkins University Applied Physics LaboratoryPresent

Assistant Research Professor The Johns Hopkins UniversityPresent

Assistant Research Professor Johns Hopkins UniversityPresent

Program Manager Intelligence Advanced Research Projects ActivityPresent

Director Cage Pharma, Inc.Present

Director eNeura TherapeuticsPresent

Partner Aura Entertainment, Shooting Gallery, Morgan Creek Productions, OtherPresent

Partner Global Domain PartnersPresent

Partner Gamma3 LLCPresent

Managing Partner, Nexus Management, L.P. Camden PartnersPresent

Co-Founder and Director Aura Entertainment, Shooting Gallery, Morgan Creek Productions, OtherPresent

Co-Founder and Director Gigantum (acq. by nVidia)Present

Co-Founder and Director GigantumPresent

Co-Founder and Managing Partner Catalio Capital ManagementPresent

Co-Founder and Managing Partner Catalio Capital Management Full-timePresent

R. Jacob Vogelstein's Education

Brown University Sc.B Bio-Electrical Engineering

The Johns Hopkins University School of Medicine Ph.D Biomedical Engineering

Investors who invest with R. Jacob Vogelstein

Scouts & Angels Affiliated With R. Jacob Vogelstein